Moderna to begin trial of new COVID vaccine to address virus variant first found in South Africa

Moderna, which makes one of the two authorized COVID-19 vaccines, is set to launch a clinical trial of a new vaccine designed to combat a variant of the virus, the company announced Wednesday.